Search

everythinglearnresearchcommunity

for

Search:↓

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The cause of atypical Cushing's syndrome in dogs, possibly linked to sex hormones, is not yet proven.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Genes related to pigmentation, body rhythms, and behavior change during hares' seasonal coat color transition, with a common genetic mechanism in two hare species.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Lower ghrelin levels and certain gene variations may increase acne risk.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Finasteride causes reduced tear flow and severe eye inflammation.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.